Morgan Stanley Sutro Biopharma, Inc. Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Morgan Stanley holds 258,595 shares of STRO stock, worth $297,384. This represents 0.0% of its overall portfolio holdings.

Number of Shares

258,595

Previous 195,860 32.03%

Holding current value

$297,384

Previous $127,000 44.09%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	BUY	$0.52 - $1.3 $32,622 - $81,555	62,735 Added 32.03%	258,595 $183,000
Q1 2025 May 15, 2025	SELL	$0.65 - $2.12 $860,779 - $2.81 Million	-1,324,276 Reduced 87.12%	195,860 $127,000
Q4 2024 Feb 14, 2025	BUY	$1.82 - $4.4 $2.27 Million - $5.48 Million	1,246,051 Added 454.62%	1,520,136 $2.8 Million
Q3 2024 May 14, 2025	SELL	$2.88 - $5.01 $39,528 - $68,762	-13,725 Reduced 4.77%	274,085 $948,000
Q3 2024 Nov 14, 2024	SELL	$2.88 - $5.01 $39,528 - $68,762	-13,725 Reduced 4.77%	274,085 $948,000
Q2 2024 May 14, 2025	SELL	$2.92 - $5.33 $3.6 Million - $6.57 Million	-1,232,326 Reduced 81.07%	287,810 $843,000
Q2 2024 Oct 17, 2024	SELL	$2.92 - $5.33 $763,743 - $1.39 Million	-261,556 Reduced 47.61%	287,810 $843,000
Q2 2024 Aug 14, 2024	SELL	$2.92 - $5.33 $763,743 - $1.39 Million	-261,556 Reduced 47.61%	287,810 $843,000
Q1 2024 Oct 17, 2024	BUY	$3.27 - $5.65 $855,288 - $1.48 Million	261,556 Added 90.88%	549,366 $3.1 Million
Q1 2024 Aug 16, 2024	BUY	$3.27 - $5.65 $1.06 Million - $1.84 Million	325,442 Added 145.34%	549,366 $3.1 Million
Q1 2024 May 15, 2024	BUY	$3.27 - $5.65 $1.06 Million - $1.84 Million	325,442 Added 145.34%	549,366 $3.1 Million
Q4 2023 Aug 16, 2024	SELL	$2.07 - $4.54 $132,244 - $290,042	-63,886 Reduced 22.2%	223,924 $960,000
Q4 2023 Feb 13, 2024	BUY	$2.07 - $4.54 $146,284 - $320,837	70,669 Added 46.11%	223,924 $960,000
Q3 2023 Nov 15, 2023	SELL	$3.29 - $4.9 $119,561 - $178,070	-36,341 Reduced 19.17%	153,255 $531,000
Q2 2023 Aug 14, 2023	BUY	$4.25 - $5.88 $192,006 - $265,646	45,178 Added 31.28%	189,596 $881,000
Q1 2023 May 15, 2023	SELL	$4.48 - $8.45 $374,120 - $705,651	-83,509 Reduced 36.64%	144,418 $667,000
Q4 2022 Feb 14, 2023	SELL	$5.41 - $8.08 $560,724 - $837,459	-103,646 Reduced 31.26%	227,927 $1.84 Million
Q3 2022 Nov 14, 2022	SELL	$5.17 - $7.11 $2,755 - $3,789	-533 Reduced 0.16%	331,573 $1.84 Million
Q2 2022 Oct 27, 2022	SELL	$3.41 - $8.95 $24,142 - $63,365	-7,080 Reduced 2.09%	332,106 $1.73 Million
Q2 2022 Aug 15, 2022	SELL	$3.41 - $8.95 $24,142 - $63,365	-7,080 Reduced 2.09%	332,106 $1.73 Million
Q1 2022 Oct 27, 2022	BUY	$7.78 - $15.31 $55,082 - $108,394	7,080 Added 2.13%	339,186 $2.79 Million
Q1 2022 May 13, 2022	BUY	$7.78 - $15.31 $2.14 Million - $4.22 Million	275,689 Added 434.18%	339,186 $2.79 Million
Q4 2021 Feb 14, 2022	BUY	$14.25 - $23.53 $532,294 - $878,939	37,354 Added 142.88%	63,497 $946,000
Q3 2021 Nov 15, 2021	BUY	$16.88 - $22.38 $441,293 - $585,080	26,143 New	26,143 $493,000

Others Institutions Holding STRO

# of Institutions

106

Shares Held

59.1M

Call Options Held

92.8K

Put Options Held

View Full List

About SUTRO BIOPHARMA, INC.

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $60M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

More about STRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account